SCHEMBL14070366

SCHEMBL14070366

c1ccc(N(c2ccccc2)c2ccc3c(ccc4cc(N(c5ccc(-c6ccc(N(c7ccc8c(ccc9cc(N(c%10ccccc%10)c%10ccccc%10)ccc98)c7)c7cccc8ccccc78)cc6)cc5)c5cccc6ccccc56)ccc43)c2)cc1

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 5/20 0.39
HSD17B10 Q99714 3/20 0.39
CYP1B1 Q16678 2/20 0.39
HIF1A Q16665 1/20 0.39
SIGMAR1 Q99720 5/20 0.38
HPRT1 P00492 3/20 0.37
CYP1A2 P05177 5/20 0.37
ERBB2 P04626 1/20 0.37
FYN P06241 1/20 0.37
MAOA P21397 1/20 0.37
ACHE P22303 1/20 0.37
AHR P35869 1/20 0.37
TDP1 Q9NUW8 2/20 0.35
CYP2A6 P11509 1/20 0.35
TSHR P16473 1/20 0.35
HPGD P15428 2/20 0.35
CYP2D6 P10635 2/20 0.34
MAPT P10636 2/20 0.33
KDM4E B2RXH2 1/20 0.33
CYP3A4 P08684 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL14070352 1.00 ALDH1A1 (0.39) ALDH1A1HSD17B10CYP1B1HIF1ASIGMAR1
SCHEMBL14070348 1.00 ALDH1A1 (0.39) ALDH1A1HSD17B10CYP1B1HIF1ASIGMAR1
SCHEMBL14070315 1.00 ALDH1A1 (0.39) ALDH1A1HSD17B10CYP1B1HIF1ASIGMAR1
SCHEMBL14070369 1.00 ALDH1A1 (0.39) ALDH1A1HSD17B10CYP1B1HIF1ASIGMAR1
SCHEMBL14070346 1.00 ALDH1A1 (0.39) ALDH1A1HSD17B10CYP1B1HIF1ASIGMAR1
SCHEMBL14070331 1.00 ALDH1A1 (0.39) ALDH1A1HSD17B10CYP1B1HIF1ASIGMAR1
SCHEMBL14070357 1.00 ALDH1A1 (0.39) ALDH1A1HSD17B10CYP1B1HIF1ASIGMAR1
SCHEMBL14070286 0.99 CYP1B1 (0.38) ALDH1A1HSD17B10CYP1B1HIF1ASIGMAR1
SCHEMBL14070174 0.99 CYP1B1 (0.38) ALDH1A1HSD17B10CYP1B1HIF1ASIGMAR1
SCHEMBL14070412 0.99 CYP1B1 (0.38) ALDH1A1HSD17B10CYP1B1HIF1ASIGMAR1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20080233434-A1 AROMATIC AMINE DERIVATIVES AND ELECTROLUMINESCENCE DEVICE USING THE SAME IDEMITSU KOSAN CO., LTD. (JP) 2008-09-25 US disclosed
US-20080233434-A1 AROMATIC AMINE DERIVATIVES AND ELECTROLUMINESCENCE DEVICE USING THE SAME IDEMITSU KOSAN CO., LTD. (JP) 2008-09-25 US disclosed
US-7405326-B2 Aromatic amine derivatives and electroluminescence device using the same IDEMITSU KOSAN CO., LTD. (JP) 2008-07-29 US disclosed
US-7405326-B2 Aromatic amine derivatives and electroluminescence device using the same IDEMITSU KOSAN CO., LTD. (JP) 2008-07-29 US disclosed
US-20070075635-A1 Organic electroluminescent device IDEMITSU KOSAN CO., LTD. (JP) 2007-04-05 US disclosed
US-20070075635-A1 Organic electroluminescent device IDEMITSU KOSAN CO., LTD. (JP) 2007-04-05 US disclosed
US-20070029927-A1 AROMATIC AMINE DERIVATIVES AND ELECTROLUMINESCENCE DEVICE USING THE SAME IDEMITSU KOSAN CO., LTD. (JP) 2007-02-08 US disclosed
US-20070029927-A1 AROMATIC AMINE DERIVATIVES AND ELECTROLUMINESCENCE DEVICE USING THE SAME IDEMITSU KOSAN CO., LTD. (JP) 2007-02-08 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20070029927-A1 AROMATIC AMINE DERIVATIVES AND ELECTROLUMINESCENCE DEVICE USING THE SAME TYR, MAOA, MAOB ALDH1A1 212/4885HSD17B10 3023/4885CYP1B1 927/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.